Influence of physical activity on metabolic state within a 3-h interruption of continuous subcutaneous insulin infusion in patients with type 1 diabetes

Diabetes Technology and Therapeutics

Volumn 13, Issue 12, 2011, Pages 1234-1239

  Jankovec, Zdenek ^a   Krcma, Michal ^a   Gruberova, Jitka ^a   Komorousova, Jana ^a   Tomesova, Jitka ^a   Zourek, Michal ^a   Rusavy, Zdenek ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; FATTY ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; INSULIN ASPART; INSULIN LISPRO; KETONE;

ADULT; AEROBIC EXERCISE; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN METABOLISM; INSULIN PUMP; INSULINEMIA; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; THERAPY DELAY; TREATMENT DURATION;

3-HYDROXYBUTYRIC ACID; ACID-BASE EQUILIBRIUM; ADULT; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; FATTY ACIDS, NONESTERIFIED; HUMANS; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; KETONE BODIES; MALE; MOTOR ACTIVITY; STATISTICS, NONPARAMETRIC;

EID: 82455189535     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0121     Document Type: Article

References (23)

1. Mecklenburg RS, Benson EA, Benson JW, Fredlund PN, Guinn T, Metz RJ, Nielsen RL, Sanner CA: Acute complications associated with insulin infusion pump therapy: report of experience with 161 patients. JAMA 1984;252:3265-3269. (Pubitemid 15183965)
2. Bending JJ, Pickup JC, Keen H: Frequency of diabetic ketoacidosis and hypoglycaemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care. Am J Med 1985;79:685-691. (Pubitemid 16170125)
3. Radermecker RP, Scheen AJ: Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and costeffectiveness. Diabetes Metab Res Rev 2004;20:178-188. (Pubitemid 38714315)
4. Newton ChA, Raskin P: Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus. Clinical and biochemical differences. Arch Intern Med 2004;164:1925-1931.
5. Egger M, Davey Smith G, Stettler C, Diem P: Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997;14: 919-928. (Pubitemid 27492182)
6. Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone M, Krinelke LG, Bolli GB: Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-Nations Trial. Diabet Med 2005;23:141-147.
7. Hanas R, Ludvigsson J: Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatr Diabetes 2006;7(Suppl 4):32-38. (Pubitemid 44122712)
8. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin pump therapy. A meta-analysis. Diabetes Care 2003;26: 1079-1087.
9. Guilhem I, Leguerrier AM, Lecordier F, Poirier JY, Maugendere D: Technical risk with subcutaneous insulin infusion. Diabetes Metab 2006;32:279-284. (Pubitemid 43966754)
10. Guerci B, Meyer L, Salle A, Charrie A, Dousset B, Ziegler O, Drouin P: Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interuption of continuous subcutaneous insulin infusion in type 1 diabetic patients. J Clin Endocrinol Metab 1999;84:2 673-2678.
11. Attia N, Jones TW, Holcombe J, Tamborlane WV: Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care 1998;21:817-821. (Pubitemid 28487078)
12. Sonnenberg GE, Kemmer FW, Berger M: Exercise in Type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Diabetologia 1990;33: 696-703. (Pubitemid 20377934)
13. Guelfi JK, Jones TW, Fournier PA: The decline in blood glucose levels is less with intermittent high-intensity compared with moderate exercise in individuals with type 1 diabetes. Diabetes Care 2005;28:1289-1294. (Pubitemid 40756687)
14. Bussau VA, Ferreira LD, Jones TW, Fournier PA: The 10-s maximal sprint. A novel approach to counter an exercisemediated fall in glycemia in individuals with type 1 diabetes. Diabetes Care 2006;29:601-606. (Pubitemid 44115361)
15. Bussau VA, Ferreira LD, Jones TW, Fournier PA: A 10-s sprint performed prior to moderate-intensity exercise prevents early post-exercise fall in glycaemia in individuals with type 1 diabetes. Diabetologia 2007;50:1815-1818. (Pubitemid 47222848)
16. The Diabetes Research in Children Network (DirectNet) Study Group: The effects of aerobic exercise on glucose and counterregulatory hormone concentrations in children with type 1 diabetes. Diabetes Care 2006;29:20-25.
17. Hermer AR, Chisholm DJ, McKenna MJ, Morfia NR, Thom JM, Bennett G, Flack JR: High-intensity training improves plasma glucose and acid-base regulation during intermitent maxima exercise in type 1 diabetes. Diabetes Care 2007;30: 1269-1271. (Pubitemid 46684660)
18. Robitaille M, Dube MC, Weisnagel SJ, Prudhome D, Massicotte D, Peronnet F, Lavore C: Substrate source utilization during moderate intensity exercise with glucose ingestion in type 1 diabetic patiens. J Appl Physiol 2007; 103:119-124. (Pubitemid 47092284)
19. Guerci B, Benichou M, Floriot P, Fougnot S, Franck P, Drolin P: Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick simplex during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients. Diabetes Care 2003;26:1137-1141. (Pubitemid 36929261)
20. Pfützner J, Forst T, Butzer R, Forst S, Weber MM, Pfützner AH, Pfützner A: Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy. Diabet Med 2006;23: 1124-1129. (Pubitemid 44401143)
21. Admon G, Weinstein Y, Falk B, Weintrob N, Benzaquen H, Ofan R, Fayman G, Zigel L, Constantini N, Phillip M: Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus. Pediatrics 2005;116:e348-e355. (Pubitemid 44336648)
22. The Diabetes Research in Children Network (DirectNet) Study Group: Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin. Diabetes Care 2006;29:2200-2204.
23. Mitchell HT, Abraham G, Schiffrin A, Leiter LA, Marliss EB: Hyperglycemia after intense exercise in IDDM subjects during continuous subcutaneous insulin infusion. Diabetes Care 1988;11:311-317.